These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 21114665)
1. Hemizygous deletions on chromosome 1p21.3 involving the DPYD gene in individuals with autism spectrum disorder. Carter MT; Nikkel SM; Fernandez BA; Marshall CR; Noor A; Lionel AC; Prasad A; Pinto D; Joseph-George AM; Noakes C; Fairbrother-Davies C; Roberts W; Vincent J; Weksberg R; Scherer SW Clin Genet; 2011 Nov; 80(5):435-43. PubMed ID: 21114665 [TBL] [Abstract][Full Text] [Related]
2. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability. Willemsen MH; Vallès A; Kirkels LA; Mastebroek M; Olde Loohuis N; Kos A; Wissink-Lindhout WM; de Brouwer AP; Nillesen WM; Pfundt R; Holder-Espinasse M; Vallée L; Andrieux J; Coppens-Hofman MC; Rensen H; Hamel BC; van Bokhoven H; Aschrafi A; Kleefstra T J Med Genet; 2011 Dec; 48(12):810-8. PubMed ID: 22003227 [TBL] [Abstract][Full Text] [Related]
3. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. Fernandez BA; Roberts W; Chung B; Weksberg R; Meyn S; Szatmari P; Joseph-George AM; Mackay S; Whitten K; Noble B; Vardy C; Crosbie V; Luscombe S; Tucker E; Turner L; Marshall CR; Scherer SW J Med Genet; 2010 Mar; 47(3):195-203. PubMed ID: 19755429 [TBL] [Abstract][Full Text] [Related]
4. FRA1E common fragile site breaks map within a 370kilobase pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD). Hormozian F; Schmitt JG; Sagulenko E; Schwab M; Savelyeva L Cancer Lett; 2007 Feb; 246(1-2):82-91. PubMed ID: 16556484 [TBL] [Abstract][Full Text] [Related]
5. Analysis of severely affected patients with dihydropyrimidine dehydrogenase deficiency reveals large intragenic rearrangements of DPYD and a de novo interstitial deletion del(1)(p13.3p21.3). van Kuilenburg AB; Meijer J; Mul AN; Hennekam RC; Hoovers JM; de Die-Smulders CE; Weber P; Mori AC; Bierau J; Fowler B; Macke K; Sass JO; Meinsma R; Hennermann JB; Miny P; Zoetekouw L; Vijzelaar R; Nicolai J; Ylstra B; Rubio-Gozalbo ME Hum Genet; 2009 Jun; 125(5-6):581-90. PubMed ID: 19296131 [TBL] [Abstract][Full Text] [Related]
6. A variant Cri du Chat phenotype and autism spectrum disorder in a subject with de novo cryptic microdeletions involving 5p15.2 and 3p24.3-25 detected using whole genomic array CGH. Harvard C; Malenfant P; Koochek M; Creighton S; Mickelson EC; Holden JJ; Lewis ME; Rajcan-Separovic E Clin Genet; 2005 Apr; 67(4):341-51. PubMed ID: 15733271 [TBL] [Abstract][Full Text] [Related]
7. Association of new deletion/duplication region at chromosome 1p21 with intellectual disability, severe speech deficit and autism spectrum disorder-like behavior: an all-in approach to solving the Brečević L; Rinčić M; Krsnik Ž; Sedmak G; Hamid AB; Kosyakova N; Galić I; Liehr T; Borovečki F Transl Neurosci; 2015; 6(1):59-86. PubMed ID: 28123791 [TBL] [Abstract][Full Text] [Related]
8. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome). Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal follow-up of autism spectrum features and sensory behaviors in Angelman syndrome by deletion class. Peters SU; Horowitz L; Barbieri-Welge R; Taylor JL; Hundley RJ J Child Psychol Psychiatry; 2012 Feb; 53(2):152-9. PubMed ID: 21831244 [TBL] [Abstract][Full Text] [Related]
10. Four patients with speech delay, seizures and variable corpus callosum thickness sharing a 0.440 Mb deletion in region 1q44 containing the HNRPU gene. Caliebe A; Kroes HY; van der Smagt JJ; Martin-Subero JI; Tönnies H; van 't Slot R; Nievelstein RA; Muhle H; Stephani U; Alfke K; Stefanova I; Hellenbroich Y; Gillessen-Kaesbach G; Hochstenbach R; Siebert R; Poot M Eur J Med Genet; 2010; 53(4):179-85. PubMed ID: 20382278 [TBL] [Abstract][Full Text] [Related]
12. Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase (DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity. Ticha I; Kleiblova P; Fidlerova J; Novotny J; Pohlreich P; Kleibl Z Cancer Chemother Pharmacol; 2009 Aug; 64(3):615-8. PubMed ID: 19288105 [TBL] [Abstract][Full Text] [Related]
13. Copy number and sequence variants implicate APBA2 as an autism candidate gene. Babatz TD; Kumar RA; Sudi J; Dobyns WB; Christian SL Autism Res; 2009 Dec; 2(6):359-64. PubMed ID: 20029827 [TBL] [Abstract][Full Text] [Related]
14. Clavicular pseudoarthrosis, anomalous coronary artery and extra crease of the fifth finger-previously unreported features in individuals with class II 1q21.1 microdeletions. Velinov M; Dolzhanskaya N Eur J Med Genet; 2010; 53(4):213-6. PubMed ID: 20573555 [TBL] [Abstract][Full Text] [Related]
15. Two cases of 5-fluorouracil toxicity linked with gene variants in the DPYD gene. Ofverholm A; Arkblad E; Skrtic S; Albertsson P; Shubbar E; Enerbäck C Clin Biochem; 2010 Feb; 43(3):331-4. PubMed ID: 19822137 [TBL] [Abstract][Full Text] [Related]
16. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. Bruno DL; Anderlid BM; Lindstrand A; van Ravenswaaij-Arts C; Ganesamoorthy D; Lundin J; Martin CL; Douglas J; Nowak C; Adam MP; Kooy RF; Van der Aa N; Reyniers E; Vandeweyer G; Stolte-Dijkstra I; Dijkhuizen T; Yeung A; Delatycki M; Borgström B; Thelin L; Cardoso C; van Bon B; Pfundt R; de Vries BB; Wallin A; Amor DJ; James PA; Slater HR; Schoumans J J Med Genet; 2010 May; 47(5):299-311. PubMed ID: 20452996 [TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum of dihydropyrimidine dehydrogenase gene (DPYD) in the Tunisian population. Ben Fredj R; Gross E; Chouchen L; B'Chir F; Ben Ahmed S; Neubauer S; Kiechle M; Saguem S C R Biol; 2007 Oct; 330(10):764-9. PubMed ID: 17905396 [TBL] [Abstract][Full Text] [Related]
19. Genome sequencing reveals a novel genetic mechanism underlying dihydropyrimidine dehydrogenase deficiency: A novel missense variant c.1700G>A and a large intragenic inversion in DPYD spanning intron 8 to intron 12. van Kuilenburg ABP; Tarailo-Graovac M; Meijer J; Drogemoller B; Vockley J; Maurer D; Dobritzsch D; Ross CJ; Wasserman W; Meinsma R; Zoetekouw L; van Karnebeek CDM Hum Mutat; 2018 Jul; 39(7):947-953. PubMed ID: 29691939 [TBL] [Abstract][Full Text] [Related]
20. Alport syndrome. Molecular genetic aspects. Hertz JM Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]